Moderna: confident of overcoming Covid variants
(CercleFinance.com) - Moderna announces updates on its COVID-19 vaccine program.
New results from a preclinical study have shown that vaccine candidates used as specific booster doses increased neutralising agents against SARS-CoV-2 variants of concern.
To date, the company has shipped approximately 132 million doses of Moderna COVID-19 vaccine worldwide.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
New results from a preclinical study have shown that vaccine candidates used as specific booster doses increased neutralising agents against SARS-CoV-2 variants of concern.
To date, the company has shipped approximately 132 million doses of Moderna COVID-19 vaccine worldwide.
Copyright (c) 2021 CercleFinance.com. All rights reserved.